Related Experiment Video
Updated: Jan 26, 2026

Investigating the Pathogenesis of MYH7 Mutation Gly823Glu in Familial Hypertrophic Cardiomyopathy using a Mouse Model
Published on: August 8, 2022
Survival After Myectomy for Obstructive Hypertrophic Cardiomyopathy: What Causes Late Mortality?
Anita Nguyen1, Hartzell V Schaff1, Rick A Nishimura2
1Department of Cardiovascular Surgery, Mayo Clinic, Rochester, Minnesota.
Insights
Survival after septal myectomy for obstructive hypertrophic cardiomyopathy is excellent. Most late deaths in these patients are unrelated to hypertrophic cardiomyopathy itself.
Area of Science:
- Cardiology
- Cardiac Surgery
- Genetics
Background:
- Obstructive hypertrophic cardiomyopathy (oHCM) is a significant cardiac condition.
- Septal myectomy is a surgical intervention for oHCM.
- Long-term survival post-myectomy is crucial to evaluate.
Purpose of the Study:
- To investigate the causes of late mortality in a large cohort of patients who underwent septal myectomy for oHCM.
- To assess the long-term survival rates and causes of death after surgical treatment for oHCM.
Main Methods:
- A retrospective review of 2,956 patients who underwent surgery for oHCM between 1961 and 2017.
- Verification of vital status and causes of mortality using LexisNexis Accurint and the National Death Index.
- Analysis of demographic data, genetic testing results, and mortality outcomes.
Main Results:
- 1-year, 10-year, and 20-year survival rates were 98%, 85%, and 52%, respectively.
- Mortality occurred in 16% of patients; hypertrophic cardiomyopathy was the primary cause in less than 20% of these deaths.
- Non-cardiac causes accounted for 44% of deaths; other cardiac causes included coronary artery disease and stroke.
Conclusions:
- Septal myectomy provides excellent long-term survival for patients with oHCM.
- The majority of late deaths are not directly attributable to hypertrophic cardiomyopathy.
- Genetic status did not significantly impact overall mortality in this cohort.
Background:
Survival of patients with obstructive hypertrophic cardiomyopathy who undergo septal myectomy appears to be excellent and, in some series, is similar to that of matched populations. In this study, we investigated causes of late death in a large cohort of surgical patients.
Methods:
Between January 1961 and October 2017, 2,956 patients underwent surgery for hypertrophic cardiomyopathy. We reviewed medical records of these patients. Vital status and causes of mortality were verified using 2 methods: LexisNexis Accurint, a commercially available resource, and the National Death Index, a government database.
Results:
The median age was 56 (interquartile range, 44 to 65) years, and 1,624 (55%) were men. Genetic testing was performed in 416, and 97 (23%) had a positive genetic test. After operation, 1-year, 10-year, and 20-year survival estimates were 98%, 85%, and 52%, respectively. Mortality occurred in 460 (16%) patients, and cause of death could be obtained in 398 (87%). Cardiac-related deaths occurred in 224 (56%), with hypertrophic cardiomyopathy the primary cause of death in 64. Other cardiac causes of mortality included coronary artery disease (n = 64), stroke (n = 23), other cardiomyopathy (n = 20), and heart failure (n = 15). Noncardiac deaths occurred in 174 (44%). Gene-positive status was not associated with overall mortality.
Conclusions:
This study, using 2 independent sources to verify vital status and cause of mortality, confirms that survival after septal myectomy is excellent. Hypertrophic cardiomyopathy was identified as the primary cause of death in less than 20%, with mortality in most patients unrelated to hypertrophic cardiomyopathy.
Related Concept Videos
Cardiomyopathy III: Hypertrophic Cardiomyopathy
Cardiomyopathy II: Dilated Cardiomyopathy
Cardiomyopathy IV: Restrictive Cardiomyopathy
Survival Tree
Building a Survival Tree
Constructing a...
Survival Curves
The Kaplan-Meier estimator is the most common method for constructing survival curves. This...
Cardiomyopathy V: Interprofessional Care

